EP0904293A4 - Interleukin-5 antagonist - Google Patents

Interleukin-5 antagonist

Info

Publication number
EP0904293A4
EP0904293A4 EP97921538A EP97921538A EP0904293A4 EP 0904293 A4 EP0904293 A4 EP 0904293A4 EP 97921538 A EP97921538 A EP 97921538A EP 97921538 A EP97921538 A EP 97921538A EP 0904293 A4 EP0904293 A4 EP 0904293A4
Authority
EP
European Patent Office
Prior art keywords
interleukin
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97921538A
Other languages
English (en)
French (fr)
Other versions
EP0904293A1 (de
Inventor
Angel Lopez
Matthew Vadas
Frances Shannon
Stan Bastiras
Allan William Hey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Hospira Adelaide Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Bresagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd, Bresagen Ltd filed Critical Medvet Science Pty Ltd
Publication of EP0904293A1 publication Critical patent/EP0904293A1/de
Publication of EP0904293A4 publication Critical patent/EP0904293A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5409—IL-5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP97921538A 1996-05-24 1997-05-23 Interleukin-5 antagonist Withdrawn EP0904293A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO0054/96 1996-05-24
AUPO0054A AUPO005496A0 (en) 1996-05-24 1996-05-24 An interleukin-5 antagonist
PCT/AU1997/000322 WO1997045448A1 (en) 1996-05-24 1997-05-23 An interleukin-5 antagonist

Publications (2)

Publication Number Publication Date
EP0904293A1 EP0904293A1 (de) 1999-03-31
EP0904293A4 true EP0904293A4 (de) 2002-03-06

Family

ID=3794368

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97921538A Withdrawn EP0904293A4 (de) 1996-05-24 1997-05-23 Interleukin-5 antagonist

Country Status (6)

Country Link
EP (1) EP0904293A4 (de)
JP (1) JP2001511641A (de)
AU (1) AUPO005496A0 (de)
CA (1) CA2256368A1 (de)
NZ (1) NZ332946A (de)
WO (1) WO1997045448A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020084841A (ko) * 1999-04-23 2002-11-11 파멕사 에이/에스 Ｉｌ5 활성을 다운-조절하는 방법
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
RU2552929C1 (ru) 2013-11-14 2015-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU553017B2 (en) * 1982-06-07 1986-06-26 Chr. Hansen A/S A process for the preparation of chymosin
AU690128B2 (en) * 1993-07-28 1998-04-23 Medvet Science Pty. Ltd. Haemopoietic growth factor antagonists

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
M. V. MILBURN ET AL: "a novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interlukin-5", NATURE., vol. 363, 13 May 1993 (1993-05-13), MACMILLAN JOURNALS LTD. LONDON., GB, pages 172 - 176, XP002186180, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
JP2001511641A (ja) 2001-08-14
NZ332946A (en) 2000-08-25
WO1997045448A1 (en) 1997-12-04
EP0904293A1 (de) 1999-03-31
AUPO005496A0 (en) 1996-06-13
CA2256368A1 (en) 1997-12-04

Similar Documents

Publication Publication Date Title
DE69736261D1 (en) Alpha-1-6-fucosyltransferasen
DE69703480D1 (en) Anionische photokatalysator
DE59707730D1 (en) Peripheralpumpe
DE69722552D1 (en) Photolithographisches gerät
GB9601353D0 (en) Stays
ZA972591B (en) Substituted 1-methyl-3-benzyluracils
GB9609151D0 (en) Cremators
GB9601590D0 (en) Flourination
DE59711583D1 (en) Heterocyclyluracile
EP0904293A4 (de) Interleukin-5 antagonist
DE59709914D1 (en) Substituierte aromatische phosphonsäurederivate
DE59705556D1 (en) Peripheralpumpe
GB9610624D0 (en) Stays
HUP9901287A3 (en) Coin-checking arrangement
GB2314376B (en) Stays
HK1018904A (en) An interleukin-5 antagonist
AU2758497A (en) An interleukin-5 antagonist
NZ314277A (en) Octopeptide somatostatin antagonist
GB9708766D0 (en) Fibrinogen receptor antagonist
AU1758P (en) Tallara Fragaria xananassa
DE69715850D1 (en) Orthopädische fixationsstift-baugruppen
GB9625926D0 (en) An improved stringe
GB9617983D0 (en) Fibrinogen receptor antagonist prodrugs
GB9617899D0 (en) Fibrinogen receptor antagonist prodrugs
TW309700U (en) Feeder structure

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020116

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020403

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1018904

Country of ref document: HK